Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness

Shahrokh F. Shariat, Alexandre R. Zlotta, Raheela Ashfaq, Arthur I Sagalowsky, Yair Lotan

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

The aim of this study was to evaluate the association between p53, p21, p27 and Rb expression, alone or in combination, with pathological features and clinical outcomes of urothelial carcinoma of the bladder. Immunohistochemical staining for p53, p21, p27 and pRB was performed on tissue microarrays comprising normal urothelium from nine controls, transurethral resection specimens from 74 patients with Ta, Tis and/or T1 bladder urothelial carcinoma, radical cystectomy specimens from 226 consecutive urothelial carcinoma patients, and lymph nodes with tumor invasion from 50 of the 226 cystectomy patients. All nine controls had normal status of biomarkers. The proportion of biomarkers alterations was highest in lymph node metastases. p53, pRB and p27 were associated with pathologic stage, lymphovascular invasion and lymph node metastases (P-values≤0.050). Each biomarker alone, each combination of two biomarkers and the number of altered biomarkers were all independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). In patients with organ-confined disease, p53, p21 and p27 were independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). There was a good but not perfect concordance in the expression of biomarkers between matched transurethral resection and cystectomy specimens (n=22; concordance rates: 77-86%) and between matched lymph node and cystectomy specimens (n=50, 70-92%). In conclusion, p53, p21, p27 and pRB have a cooperative/synergistic role in the biologic behavior of bladder urothelial carcinoma. In contrast to the use of single biological markers, evaluation of their combined status may improve prognostic models and help identify patients who might benefit from adjuvant therapies and in decision-making.

Original languageEnglish (US)
Pages (from-to)445-459
Number of pages15
JournalModern Pathology
Volume20
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Urinary Bladder Neoplasms
Cell Cycle
Biomarkers
Cystectomy
Lymph Nodes
Carcinoma
Urinary Bladder
Neoplasm Metastasis
Recurrence
Urothelium
Decision Making
Staining and Labeling
Neoplasms

Keywords

  • Bladder cancer
  • p21
  • p27
  • p53
  • Progression
  • Retinoblastoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. / Shariat, Shahrokh F.; Zlotta, Alexandre R.; Ashfaq, Raheela; Sagalowsky, Arthur I; Lotan, Yair.

In: Modern Pathology, Vol. 20, No. 4, 04.2007, p. 445-459.

Research output: Contribution to journalArticle

@article{aeaf2b934e4243619da1161efcbad165,
title = "Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness",
abstract = "The aim of this study was to evaluate the association between p53, p21, p27 and Rb expression, alone or in combination, with pathological features and clinical outcomes of urothelial carcinoma of the bladder. Immunohistochemical staining for p53, p21, p27 and pRB was performed on tissue microarrays comprising normal urothelium from nine controls, transurethral resection specimens from 74 patients with Ta, Tis and/or T1 bladder urothelial carcinoma, radical cystectomy specimens from 226 consecutive urothelial carcinoma patients, and lymph nodes with tumor invasion from 50 of the 226 cystectomy patients. All nine controls had normal status of biomarkers. The proportion of biomarkers alterations was highest in lymph node metastases. p53, pRB and p27 were associated with pathologic stage, lymphovascular invasion and lymph node metastases (P-values≤0.050). Each biomarker alone, each combination of two biomarkers and the number of altered biomarkers were all independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). In patients with organ-confined disease, p53, p21 and p27 were independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). There was a good but not perfect concordance in the expression of biomarkers between matched transurethral resection and cystectomy specimens (n=22; concordance rates: 77-86{\%}) and between matched lymph node and cystectomy specimens (n=50, 70-92{\%}). In conclusion, p53, p21, p27 and pRB have a cooperative/synergistic role in the biologic behavior of bladder urothelial carcinoma. In contrast to the use of single biological markers, evaluation of their combined status may improve prognostic models and help identify patients who might benefit from adjuvant therapies and in decision-making.",
keywords = "Bladder cancer, p21, p27, p53, Progression, Retinoblastoma",
author = "Shariat, {Shahrokh F.} and Zlotta, {Alexandre R.} and Raheela Ashfaq and Sagalowsky, {Arthur I} and Yair Lotan",
year = "2007",
month = "4",
doi = "10.1038/modpathol.3800757",
language = "English (US)",
volume = "20",
pages = "445--459",
journal = "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness

AU - Shariat, Shahrokh F.

AU - Zlotta, Alexandre R.

AU - Ashfaq, Raheela

AU - Sagalowsky, Arthur I

AU - Lotan, Yair

PY - 2007/4

Y1 - 2007/4

N2 - The aim of this study was to evaluate the association between p53, p21, p27 and Rb expression, alone or in combination, with pathological features and clinical outcomes of urothelial carcinoma of the bladder. Immunohistochemical staining for p53, p21, p27 and pRB was performed on tissue microarrays comprising normal urothelium from nine controls, transurethral resection specimens from 74 patients with Ta, Tis and/or T1 bladder urothelial carcinoma, radical cystectomy specimens from 226 consecutive urothelial carcinoma patients, and lymph nodes with tumor invasion from 50 of the 226 cystectomy patients. All nine controls had normal status of biomarkers. The proportion of biomarkers alterations was highest in lymph node metastases. p53, pRB and p27 were associated with pathologic stage, lymphovascular invasion and lymph node metastases (P-values≤0.050). Each biomarker alone, each combination of two biomarkers and the number of altered biomarkers were all independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). In patients with organ-confined disease, p53, p21 and p27 were independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). There was a good but not perfect concordance in the expression of biomarkers between matched transurethral resection and cystectomy specimens (n=22; concordance rates: 77-86%) and between matched lymph node and cystectomy specimens (n=50, 70-92%). In conclusion, p53, p21, p27 and pRB have a cooperative/synergistic role in the biologic behavior of bladder urothelial carcinoma. In contrast to the use of single biological markers, evaluation of their combined status may improve prognostic models and help identify patients who might benefit from adjuvant therapies and in decision-making.

AB - The aim of this study was to evaluate the association between p53, p21, p27 and Rb expression, alone or in combination, with pathological features and clinical outcomes of urothelial carcinoma of the bladder. Immunohistochemical staining for p53, p21, p27 and pRB was performed on tissue microarrays comprising normal urothelium from nine controls, transurethral resection specimens from 74 patients with Ta, Tis and/or T1 bladder urothelial carcinoma, radical cystectomy specimens from 226 consecutive urothelial carcinoma patients, and lymph nodes with tumor invasion from 50 of the 226 cystectomy patients. All nine controls had normal status of biomarkers. The proportion of biomarkers alterations was highest in lymph node metastases. p53, pRB and p27 were associated with pathologic stage, lymphovascular invasion and lymph node metastases (P-values≤0.050). Each biomarker alone, each combination of two biomarkers and the number of altered biomarkers were all independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). In patients with organ-confined disease, p53, p21 and p27 were independently associated with disease recurrence and bladder cancer-specific death (P-values≤0.046). There was a good but not perfect concordance in the expression of biomarkers between matched transurethral resection and cystectomy specimens (n=22; concordance rates: 77-86%) and between matched lymph node and cystectomy specimens (n=50, 70-92%). In conclusion, p53, p21, p27 and pRB have a cooperative/synergistic role in the biologic behavior of bladder urothelial carcinoma. In contrast to the use of single biological markers, evaluation of their combined status may improve prognostic models and help identify patients who might benefit from adjuvant therapies and in decision-making.

KW - Bladder cancer

KW - p21

KW - p27

KW - p53

KW - Progression

KW - Retinoblastoma

UR - http://www.scopus.com/inward/record.url?scp=33947578925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947578925&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800757

DO - 10.1038/modpathol.3800757

M3 - Article

C2 - 17384651

AN - SCOPUS:33947578925

VL - 20

SP - 445

EP - 459

JO - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

JF - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

SN - 0893-3952

IS - 4

ER -